Development of improved SRC-3 inhibitors as breast cancer therapeutic agents.
Qin L, Chen J, Lu D, Jain P, Yu Y, Cardenas D, Peng X, Yu X, Xu J, Wang J, O'Malley BW, Lonard DM.
Qin L, et al.
Endocr Relat Cancer. 2021 Aug 13;28(10):657-670. doi: 10.1530/ERC-20-0402.
Endocr Relat Cancer. 2021.
PMID: 34310341
Free PMC article.